Research progress on berberine with a special focus on its oral bioavailability

CS Liu, YR Zheng, YF Zhang, XY Long - Fitoterapia, 2016 - Elsevier
The natural product berberine (BBR) has become a potential drug in the treatment of
diabetes, hyperlipidemia, and cancer. However, the oral delivery of BBR is challenged by its …

Pharmaceutical nanotechnology for oral delivery of anticancer drugs

L Mei, Z Zhang, L Zhao, L Huang, XL Yang… - Advanced drug delivery …, 2013 - Elsevier
Oral chemotherapy is an important topic in the 21st century medicine, which may radically
change the current regimen of chemotherapy and greatly improve the quality of life of the …

Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor

E Fox, SE Bates - Expert review of anticancer therapy, 2007 - Taylor & Francis
P-glycoprotein actively transports structurally unrelated compounds out of cells, conferring
the multidrug resistance phenotype in cancer. Tariquidar is a potent, specific …

Improving cancer chemotherapy with modulators of ABC drug transporters

S Shukla, S Ohnuma, SV Ambudkar - Current drug targets, 2011 - ingentaconnect.com
ATP-binding cassette (ABC) transporters, P-glycoprotein (P-gp, ABCB1) and ABCG2, are
membrane proteins that couple the energy derived from ATP hydrolysis to efflux many …

Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs

P Breedveld, JH Beijnen, JHM Schellens - Trends in pharmacological …, 2006 - cell.com
P-glycoprotein (ABCB1) and breast cancer resistance protein [BCRP (also known as
ABCG2)] are drug efflux transporters of the ATP binding cassette (ABC) family of proteins …

Drug interactions in oncology

JH Beijnen, JHM Schellens - The lancet oncology, 2004 - thelancet.com
Drug interactions are an ongoing concern in treatment of cancer, especially when cytotoxic
drugs are being used. However, the clinical relevance of these interactions is not always …

Concise review: clinical relevance of drug–drug and herb–drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein)

S Marchetti, R Mazzanti, JH Beijnen… - The …, 2007 - academic.oup.com
Learning Objectives After completing this course, the reader will be able to: Identify
important sources of variability in drug exposure caused by drug interactions mediated by P …

Cellular and clinical pharmacology of the taxanes docetaxel and paclitaxel–a review

VA de Weger, JH Beijnen, JHM Schellens - Anti-cancer drugs, 2014 - journals.lww.com
Paclitaxel and docetaxel are active against a range of human cancers. Their antitumor
activity is based on stabilization of the microtubule dynamics and thereby disruption of the …

Intestinal permeability and its relevance for absorption and elimination

H Lennernäs - Xenobiotica, 2007 - Taylor & Francis
Human jejunal permeability (P eff) is determined in the intestinal region with the highest
expression of carrier proteins and largest surface area. Intestinal P eff are often based on …

Mutant V599EB-Raf Regulates Growth and Vascular Development of Malignant Melanoma Tumors

A Sharma, NR Trivedi, MA Zimmerman, DA Tuveson… - Cancer research, 2005 - AACR
Activating mutations of the B-RAF gene are observed in> 60% of human melanomas.
Approximately 90% of these mutations occur in the activation segment of the kinase domain …